This page lists the SEC filings reported by ESHELMAN FREDRIC N.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2011-11-15 | ESHELMAN FREDRIC N | Furiex Pharmaceuticals, Inc. | 1,732,729 | 17.5% | EDGAR |
| SC 13D/A | 2011-11-09 | ESHELMAN FREDRIC N | Furiex Pharmaceuticals, Inc. | 1,718,893 | 17.4% | EDGAR |
| SC 13D/A | 2011-05-27 | ESHELMAN FREDRIC N | Furiex Pharmaceuticals, Inc. | 1,454,823 | 14.7% | EDGAR |
| SC 13D/A | 2011-05-23 | ESHELMAN FREDRIC N | Furiex Pharmaceuticals, Inc. | 1,190,307 | 12.0% | EDGAR |
| SC 13D | 2011-05-03 | ESHELMAN FREDRIC N | Furiex Pharmaceuticals, Inc. | 700,109 | 7.1% | EDGAR |
| SC 13G/A | 2011-02-14 | ESHELMAN FREDRIC N | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 70 | 7.0% | EDGAR |
| SC 13G | 2011-02-14 | ESHELMAN FREDRIC N | Furiex Pharmaceuticals, Inc. | 634,233 | 6.4% | EDGAR |
| SC 13G/A | 2010-02-12 | ESHELMAN FREDRIC N | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 8,412,933 | 7.1% | EDGAR |
| SC 13G/A | 2009-02-12 | ESHELMAN FREDRIC N | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 8,444,582 | 7.2% | EDGAR |
| SC 13G/A | 2008-02-13 | ESHELMAN FREDRIC N | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 8,564,415 | 7.2% | EDGAR |
| SC 13G/A | 2007-02-13 | ESHELMAN FREDRIC N | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 9,614,582 | 8.2% | EDGAR |
| SC 13G/A | 2006-02-01 | ESHELMAN FREDRIC N | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 4,954,325 | 8.5% | EDGAR |
| SC 13G | 2005-02-01 | ESHELMAN FREDRIC N | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 5,337,075 | 9.4% | EDGAR |
| SC 13G/A | 2004-02-11 | ESHELMAN FREDRIC N | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 5,302,408 | 9.5% | EDGAR |
| SC 13G/A | 2003-02-07 | ESHELMAN FREDRIC N | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 5,543,407 | 10.0% | EDGAR |
| SC 13G/A | 2002-02-07 | ESHELMAN FREDRIC N | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 9 | 11.0% | EDGAR |
| SC 13G | 2001-02-12 | ESHELMAN FREDRIC N | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 3,034,444 | 12.0% | EDGAR |
| SC 13G | 2000-02-09 | ESHELMAN FREDRIC N | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 3,054,211 | 12.4% | EDGAR |
| SC 13G | 2000-02-09 | ESHELMAN FREDRIC N | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 3,054,211 | 12.4% | EDGAR |
| SC 13G | 2000-02-09 | ESHELMAN FREDRIC N | PHARMACEUTICAL PRODUCT DEVELOPMENT INC | 3,054,211 | 12.4% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.